Neuroendocrine aspects of the serotonergic hypothesis of depression
References (199)
- et al.
The effects of mianserin therapy on plasma renin activity in depressed patients
Biol. Psychiatry
(1986) - et al.
The neuroendocrine response to fenfluramine in depressive and normal controls
Neuroendocrinology
(1988) - et al.
Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes
Eur. J. Pharmacol.
(1988) - et al.
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
Eur. J. Pharmacol.
(1988) - et al.
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
Pharmacol. Biochem. Behav.
(1988) - et al.
Implication of the serotonergic system in the decreased ACTH response to stress after lesion of the amygdaloid central nucleus
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1985) - et al.
Serotonin 5-HT2 receptor binding on blood platelets—A peripheral marker of depression?
Life Sci.
(1987) - et al.
Effect of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami
Peptides
(1989) - et al.
Diminished prolactin responses to repeated fenfluramine challenge in man
Psychiatry Res.
(1987) - et al.
Role of biogenic amines in opioid peptide-induced secretion of pituitary hormones
Pharmacol. Res. Commun.
(1980)
Effects of d- and l-fenfluramine on striatal homovanillic acid concentrations in rats after pharmacological manipulation of brain serotonin
Pharmacol. Res. Commun.
(1980)
Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex
Neuropharmacology
(1985)
Decreased 5-HT2 but not 5-HT1 receptor binding in cortex of rat after chronic administration of dothiepin
Neuropharmacology
(1985)
A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICX 205 930
Eur. J. Pharmacol.
(1988)
Serotonergic mechanisms in the behavioral effects of buspirone and gepirone
Pharmacol. Biochem. Behav.
(1986)
Biochemical assessment of the central 5-HT agonist activity RU 24969 (a piperidinyl indole)
Eur. J. Pharmacol.
(1980)
Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion
Brain Res. Bull.
(1987)
Effect of central serotonin depletion on adrenocortical responses to neural stimuli
Exp. Neurol.
(1984)
Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers
Biol. Psychiatry
(1989)
Fluoxetine in the treatment of obsessive compulsive disorder
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1985)
Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-treated rats
Pharmacol. Res. Commun.
(1981)
Interactions of trazodone with serotonin neurons and receptors
Neuropharmacology
(1984)
Further evidence that methergoline is a central 5-hydroxytryptamine receptor blocking agent
Neurosci. Lett.
(1978)
Activation of the 5-HT1A receptor subtype increases plasma ACTH concentration
Eur. J. Pharmacol.
(1988)
Buspirone: action on serotonin receptors in calf hippocampus
Eur. J. Pharmacol.
(1983)
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain
Eur. J. Pharmacol.
(1987)
8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in female rats
Eur. J. Pharmacol.
(1989)
Neurotransmitter metabolites and endocrine responses in depression
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1985)
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I] iodocyanopindolol, [3H]mesulergine and [3H]ketanserin
Eur. J. Pharmacol.
(1985)
Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells
Eur. J. Pharmacol.
(1987)
Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites
Brain. Res.
(1986)
5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra
Eur. J. Pharmacol.
(1988)
D- and 1-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat
Eur. J. Pharmacol.
(1986)
Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat
Eur. J. Pharmacol.
(1985)
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Biochem. Pharmacol.
(1968)
Comparison of stress response in male and female rats: Pituitary cyclic AMP and plasma prolactin, growth hormone and corticosterone
Psychoneuroendocrinology
(1983)
Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation
Eur. J. Pharmacol.
(1987)
Serotonergic control of prolactin release in male rats
Life Sci.
(1979)
Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats
J. Pharmacol. Exp. Ther.
(1987)
Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects
Am. J. Psychiatry
(1989)
An autoradiographic analysis of the differential ascending projections of the dorsal raphe and median raphe nuclei in the rat
J. Comp. Neurol.
(1978)
Effect of fenfluramine on prolactin secretion in obese patients: Evidence for serotonergic regulation in man
Clin. Endocrinol.
(1983)
Dorsal raphe-hypothalamic projections provide the stimulatory serotonergic input to suckling-induced prolactin release
Endocrinology
(1983)
3,4-methylenedioxy methamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites
J. Pharmacol. Exp. Ther.
(1987)
Serotoninergic involvement in the cimetidine-induced prolactin release
Endocrinology
(1983)
5,7-Dihydroxytryptamine: Improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine
J. Neurochem.
(1975)
The role of serotonin in schizophrenia
Schizophr. Bull.
(1988)
Brain serotonin depletion alters the vasopressin secretory response to osmotic stimulation and the plasma levels of angiotensin II to hypovolemia
Soc. Neurosci. Abstr.
(1987)
Neuropharmacological characterization of serotonergic stimulation of vasopressin secretion in conscious rats
Neuroendocrinology
(1988)
Involvement of neurones containing 5-Hydroxytryptamine in the mechanism of prolactin release induced by oestrogen
J. Endocrinol.
(1974)
Cited by (62)
Sex differences in Corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity
2014, Biological PsychiatryCitation Excerpt :In addition to sex differences in CRFr1 localization and GABAergic responses to CRF, this suggests that 5-HT neurons in females require a greater depolarizing stimulus to generate neuronal firing and subsequent 5-HT release, even at baseline. Compared with males, this might translate to 5-HTergic hypofunction in females, an underlying risk factor for the development of affective disorders during stress exposure (81,82). Overall, these studies revealed intriguing sex differences in behavioral and physiological effects of CRFr1 antagonist and CRF in the DR, which were mechanistically associated with sex differences in receptor co-expression and divergent electrophysiological responses to CRF in 5-HTergic neurons.
Serotonin neurons derived from rhesus monkey embryonic stem cells: Similarities to CNS serotonin neurons
2004, Experimental NeurologyPlatelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women
2004, Psychiatry ResearchThe effects of paroxetine and tianeptine on peripheral biochemical markers in major depression
2002, Progress in Neuro-Psychopharmacology and Biological PsychiatryEffects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques
2002, Psychoneuroendocrinology
Copyright © 1989 Published by Elsevier Ltd.